LPTX
Leap Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.77
−3.15%Latest reported
- Last report date
- Mar 16, 2026
- EPS actual
- $0.89
- EPS estimate
- -$0.07
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +368.6%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 11, 2026